Kinase Suppressor of Ras1 (KSR1) functions as a positive modulator of Ras-dependent signaling either upstream of or parallel to Raf-1, and pharmacologic inactivation of KSR1 may serve as a treatment for Ras-driven malignancies such as pancreatic cancer [Xing et al., (2003 ) Nat. Med. 9: 1266-1268. While some studies demonstrated a requirement for KSR1 kinase activity for its action, others suggested KSR1 acts primarily as a scaffold facilitating assembly of the c-Raf-1/MEK module. We recently established a two-stage in vitro reconstitution assay to measure KSR1 kinase activity [Xing et al., (2000) J. Biol. Chem. 275:17276-80]. In this assay, KSR1, immunopurified to apparent homogeneity, never comes in contact with recombinant kinases other than c-Raf-1. In the first assay stage, activated KSR1 is incubated with recombinant c-Raf-1 and ATP. In the second stage, activated c-Raf-1 is separated from KSR1, and incubated with unactivated MEK1, unactivated MAPK, Elk-1 and ATP. Elk-1 phosphorylation serves as a specific readout for MAPK activation. However, since KSR1 constitutively associates with MEK1 and this interaction appears critical for KSR1 scaffolding function, it has been argued that the kinase activity detected is an artifact of KSR1-bound MEK1. To address these concerns, we depleted as much as 90% of KSR1-bound MEK1 by high salt washing without altering KSR1 kinase activity. Further, complete inactivation of KSR1-bound MEK1 by pre-treating with the MEK inhibitor PD 98059 prior to the first assay stage, did not alter KSR1 kinase activity. In addition, omission of exogenous recombinant GST-MEK1 from the reaction mixture during the second assay stage abolished Elk-1 phosphorylation confirming KSR1-bound MEK1 does not support MAPK activation in our in vitro assay.
Introduction
Kinase Suppressor of Ras1 (KSR1) was originally identified in Drosophila melanogaster and Caenorhabditis elegans to function as a positive modulator of RasMitogen-activated Protein Kinase (MAPK) signaling either upstream of or parallel to cRaf-1(1-3). Since its discovery as a component of the Ras pathway, much effort has been invested to elucidate the precise role of KSR1 in the regulation of the MAPK cascade.
However, a confusing and often contradictory picture of the role of this protein in signal transduction has emerged. In particular, the presence of an Arg in kinase subdomain II of mouse and human KSR1 instead of the conserved Lys normally involved in ATP binding in mammalian kinases has led to the suggestion that mammalian KSR1 might not even function as a kinase. However, conversion of Arg to Lys, which should restore kinase activity to KSR1 if the Arg in subdomain II were naturally inactivating, failed to alter KSR1 inhibition of Germinal Vesicle Breakdown (GVBD) (4) or Elk-1 activation (5).
Further, recent studies showed that some kinases including protein kinase C-ι (6), the Cak1-like cyclin-dependent kinase-activating kinases (7, 8) , and WNK1 [for with no lysine (K)] (9-11) display full kinase activity independent of the conserved Lys in subdomain II. Consistent with this observation, Morrison and co-workers published that KSR1 binds ATP (12) . Nevertheless, the inability of a number of groups to detect KSR1 kinase activity in vitro (3, 13, 14) and the capacity of KSR1 to interact constitutively (12, 15) with MEK1, and in a Ras-dependent manner with c-Raf-1 and MAPK (4, 13, (16) (17) (18) (19) (20) , has led to the proposal that KSR1 might solely act as a scaffold protein coordinating the assembly of the c-Raf/MEK1/MAPK module.
In our experience, however, KSR1 consistently displays kinase activity in an in vitro assay in which the entire MAPK cascade is reconstituted with individual recombinant components (21) (22) (23) (24) . The inability to detect the kinase activity of KSR1 arose in part from lack of a standardized assay. To address this issue, we established a two-stage in vitro kinase activity assay for KSR1 in which KSR1 never comes in contact by guest on September 16, 2017 http://www.jbc.org/ Downloaded from with any recombinant kinases other than c-Raf-1. In the first stage of the assay, activated KSR1, purified to homogeneity, is incubated with recombinant c-Raf-1 in the presence of ATP. In the second stage of the assay, phosphorylated and activated c-Raf-1 is separated from KSR1, and incubated with unactivated GST-MEK1, unactivated GST-MAPK, Elk-1 and ATP. Elk-1 phosphorylation serves as a specific readout for MAPK activation.
Using this approach, we demonstrated that KSR1, purified to homogeneity, retained its activity to reconstitute c-Raf-1-dependent MAPK activation in vitro (23) . In addition, we provided evidence that Thr 269 is the major c-Raf-1 site trans-phosphorylated by KSR1
and that such phosphorylation appears pre-requisite for optimal activation of c-Raf-1 by KSR1 in response to stimulation by physiologic doses of EGF (24). Further, two additional groups have detected kinase activity of KSR1 using this assay. Polk and colleagues have delineated the kinase function of KSR1 in TNFα signaling in YAMC colon cancer cells (25, 26) . In their studies, KSR1 kinase activity couples TNFα signaling to MAPK-and NFκB-dependent cell survival pathways via threonine phosphorylation of c-Raf-1. Moreover, Studzinski and co-workers (27, 28) recently reported that KSR1 is up-regulated in HL60 cells undergoing differentiation induced by low doses of 1,25-dihydroxyvitamin D 3 (1,25D 3 ). This differentiation required phosphorylation of c-Raf-1 by KSR1 kinase.
Since MEK1 and KSR1 association is constitutive and such interaction is critical for the scaffolding function of KSR1 in MAPK signaling, others suggest that KSR1-bound MEK1 may be responsible for the kinase activity of KSR1 detected in our twostage assay (15) . To address these concerns, the contribution of KSR1-bound MEK1 to the kinase activity of KSR1 was assessed directly. We show that as much as 90% of KSR1-bound MEK1 can be depleted by multiple high salt washes, yet >90% of the specific activity of KSR1 is retained. Further, MAPK activation in vitro is not altered upon treatment of KSR1-bound active MEK1 with the inhibitor PD 98059 prior to conducting the two-stage assay. In addition, KSR1-bound MEK1 is not sufficient to activate MAPK in vitro since omission of exogenous recombinant GST-MEK1 from the reaction mixture in the second stage of the assay completely abolished MAPK activation.
Moreover, the kinase-inactive mutant Flag-Ki-KSR1 D683A/D700A constitutively bound MEK1 as efficiently as wild type Flag-KSR1, indicating that lack of kinase activity of
is not a result of defective MEK1 binding. These results collectively support our contention that the kinase activity of KSR1 is an intrinsic property of this protein independent of KSR1-bound endogenous MEK1. 
Materials and Methods
Expression of KSR1 in COS-7 cells and EGF treatment -COS-7 cells (ATCC) were maintained in high glucose DME medium supplemented with 10% fetal bovine serum (GIBCO BRL), penicillin and streptomycin at 37ºC in 5% CO 2 . The plasmids pCDNA3-Flag-KSR1 and pCDNA3-Flag-Ki-KSR1 (D683A/D700A) were generated as described (21) . For EGF studies, COS-7 cells were plated at a density of 1.0 NP-40, 2 mM EDTA, 1 mM PMSF, 10 µg/ml leupeptin/soybean trypsin inhibitor, 5 mM NaVO 4 ). The homogenate was centrifuged at 10,000 x g for 5 min at 4ºC, the supernatant collected, pre-cleared with Protein A/G-Agarose (Amersham), and protein content measured using BCA Reagent A (Pierce). Lysates were divided into aliquots and stored at -80ºC for subsequent use in the kinase assays, and for Western blot analysis as described (23) .
Two-stage KSR1 Activity Assay-KSR1 kinase activity was measured by the two-stage assay as previously described (23) . Briefly, Flag-KSR1 or Flag-Ki-KSR1, immunoprecipitated from 500 µg total cell lysates with 60 µl of agarose-conjugated anti- 
Results and Discussion
Multiple high salt washes remove MEK1 from KSR1 immune complexes without altering KSR1 specific activity
The inability to detect the kinase activity of KSR1 arose in part from lack of a standardized assay. To address this issue, we recently established a two-stage in vitro kinase activity assay in which KSR1, immunopurified to apparent homogeneity by multiple high salt washes, never comes in contact with any recombinant kinases other than c-Raf-1 during the first stage of the assay (23) . The amounts of recombinant proteins used in the assay are titrated individually so that in the absence of KSR1, phosphorylation of Elk-1, the specific readout for MAPK activation, is hardly detectable.
Using this approach, we demonstrated that multiple high salt washes are effective in removing various proteins (c-Raf-1, MEK1 and MAPK) normally associated with KSR1.
Nevertheless, activated KSR1, purified to homogeneity, retained its activity to reconstitute c-Raf-1-dependent MAPK activation in vitro. In contrast, a kinase-inactive mutant in which two conserved aspartic residues (D683/D700) have been mutated to alanine residues, is incapable of eliciting c-Raf-1 activation (23) (24) (25) (26) (27) (28) . From these observations, we and others concluded that the kinase function of KSR1 is required for optimal activation of the Raf-1/MAPK cascade. However, due to constitutive binding of KSR1 and MEK1, it has been suggested that the kinase activity of KSR1, detected by the two-stage assay, could be a result of contaminating active MEK1 directly participating in the in vitro assay (15) .
To address these concerns, the contribution of KSR1-bound MEK1 to the detected KSR1 activity was quantified after low salt (0.15 M NaCl-NP 40 buffer x 5) and high salt (1.0 M NaCl-NP 40 buffer x 5) washes. of endogenous MEK1 present in the KSR1 immune complex.
Inactivation of KSR1-bound MEK1 with PD 98059 has no effect on KSR1 activity
To confirm that MEK1 present in the KSR1 immune complex does not affect the KSR1 activity measured, KSR1-bound MEK1 was inactivated by treatment with the specific MEK inhibitor PD 98059 prior to performing the two-stage KSR1 activity assay. We reasoned that if the detected KSR1 activity is derived from contaminating active MEK1, inactivation of MEK1 should significantly decrease KSR1 activity.
Recombinant activated GST-MEK1 was used as a positive control for the effectiveness of PD 98059 inhibition. Figure 1 shows that PD 98059 treatment completely abolished the activation of MAPK by recombinant GST-MEK1 (top panel, lanes 1 vs. 2).
However, treatment of the KSR1/MEK1 complex after low salt (Fig. 1, lane 3 ) and high salt (Fig. 1, lane 5) washes with 100 µM PD 98059 prior to the first stage of the assay had no effect on the two-stage assay (Fig. 1, top In a recent publication, Therrien and colleagues reported that in Drosophila KSR1 functions as a scaffold by facilitating the assembly of the RAF/MEK module which in turn enhances phosphorylation of MEK by RAF (15) . In their studies, the two conserved aspartic residues (D800/D817) of Drosophila KSR1, corresponding to D683/D700 of mouse KSR1, were mutated to alanine residues to generate a kinase-defective mutant similar to our Flag-Ki-KSR1
D683A/D700A mutant (23). dsKSR1
was defective in its ability to interact with dsMEK1 and failed to stimulate Drosophila RAF autophosphorylation and resultant MEK phosphorylation. They concluded from these observations that the lack of kinase activity in our Flag-Ki-KSR D683A/D700A mutant is likely due to its inability to interact with MEK1, which in turn is incapable of assembling the c-Raf-1/MEK module required to enhance c-Raf-1 autophosphorylation. In our prior studies (24), the possibility of increased c-Raf-1 autophosphorylation by Flag-KSR1 was ruled out by using a purified kinase-inactive c-Raf-1 (K375M) mutant as a substrate which was phosphorylated on threonine residues to the same extent as the wild type cRaf-1 during the first stage of the assay. This effect was abolished when threonine 269, the putative KSR1 phosphorylation site on c-Raf-1, was mutated to alanine. We thus concluded that mouse KSR1 activation of c-Raf-1 is likely achieved via transphosphorylation of the threonine 269 residue of c-Raf-1.
To assess the ability of mouse Flag-Ki-KSR1 to interact with endogenous MEK1, equal amounts of Flag-KSR1 or Flag-Ki-KSR1 were immunoprecipitated from nonstimulated or 10 ng/ml EGF-stimulated COS-7 total lysates and washed 5 times with low salt-containing NP-40 lysis buffer (Fig. 3, upper lacks the kinase function required for optimal MAPK activation, rather than being defective in MEK1 scaffolding function.
In summary, we present four lines of evidence that the kinase function of immunoprecipitated KSR1 is an intrinsic property of KSR1 rather than an artifact of bound MEK1. We show that multiple high salt washes remove MEK1 from KSR1 immune complexes without altering KSR1 specific activity. Further, inactivation of KSR1-bound MEK1 with PD 98059 has no effect on KSR1 activity. loss-of-function mutants in C. elegans and in Drosophila (14, 15) . Alternately, three independent laboratories now claim to detect KSR1 kinase activity in preparations purified to homogeneity and report "kinase-dead" KSR1, generated by substitution of two conserved Asp residues involved in phosphotransfer, serves dominant negative function (23) (24) (25) (26) (27) (28) . In general these latter groups showed that KSR1 overexpression increases signaling through the MAPK cascade and enhances MAPK-mediated biologic responses, while dominant negative "kinase-dead" KSR1 abrogates MAPK signaling and biologic readouts including BAD-mediated apoptosis in COS-7 cells (22), vitamin Dmediated differentiation of HL60 human leukemia cells (27, 28) , survival of YAMC colon carcinoma cells upon TNF treatment (25, 26) , and EGF receptor-driven A431 human epidermoid carcinoma tumorigenesis in vitro and as xenografts in nude mice (29) .
While the reasons for these differing results is not apparent from the available data, differences in protocols and systems utilized may have played a role in the experimental outcome. The kinase activity of KSR1 appears to be "off" in most resting cells. For instance in COS-7 cells or YAMC colon cancer cells, KSR1 activity is undetectable prior to EGF or TNFα stimulation (23, 26) . Further, the activity is only on transiently. During EGF stimulation of COS-7 or A431 cells, KSR1 activity peaks at 3 min and returns to baseline by 10 min (23). Hence, it would be easy to miss the activity unless activation conditions were defined in great detail. Further, most studies that failed to detect the kinase activity of KSR1 were performed in overexpression systems that far exceed physiologic levels. KSR1 is in low abundance even compared to its target c-Raf-1, a protein also considered to be of low abundance. Therrien and co-workers estimated that dsKSR represented <1% of the level of endogenous RAF or MEK in S2 cells (15) . Guan and co-workers similarly reported almost undetectable levels of KSR1 in 293T cells (14) , yet nonetheless showed that overexpressed KSR1 quantitatively bound endogenous MEK. Under these conditions both the biologic activity of KSR1 and cellular localization of KSR1 may be altered, often yielding opposite biologic effects to low dose expression (13, 30) . In contrast, the groups that claim to be able to detect KSR1 activity have often supported their assertion by demonstrating such activity in immunoprecipitates of endogenous KSR1 (23, 24, 26, 27) . Hence, activity of endogenous KSR1 from YAMC, COS-7, A431 and HL60 cells has been reported. Lastly, the systems used to assess activity differ greatly. The strongest evidence against there being a kinase activity associated with KSR1 is derived from genetic models in non-mammalian systems 
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Flag-KSR1(500 µg) Table 1 . Quantitation of endogenous MEK1 bound to Flag-KSR1 and Flag-Ki-KSR1 and specific activity of KSR1 after low salt or high salt washes. COS-7 cells, transfected with Flag-tagged mouse wild type KSR1 or Ki-KSR1, were treated with 10 ng/ml EGF for 3 min. KSR1 was immunoprecipitated from 500 µg of lysate for each reaction point and washed 5 times with either 0.15 M NaCl or 1.0 M NaCl-containing NP-40 buffer as indicated. The kinase activity of KSR1 was determined in a two-stage in vitro reconstitution assay using Elk-1 phosphorylation as a specific readout, as described under "Materials and Methods". Immunoprecipitated Flag-KSR1 or Ki-KSR1, KSR1-bound MEK1 or phosphorylated Elk-1, resolved by 7.5% SDS-PAGE, were visualized by Western blot using a mouse anti-Flag M2, a rabbit anti-MEK1 or a rabbit anti-phospho-Elk-1 (Ser-383) Ab, respectively, quantified by densitometry and presented in arbitary OD units. * Basal and EGF-stimulated KSR1 activity was calculated by deduction of the background activity of recombinant proteins in the absence of Flag-KSR1 (representing <5% EGFstimulated activity). 40 µg COS-7 lysate was used as a control for endogenous MEK1 expression and for calculating the percent of cellular MEK1 associated with Flag-KSR1 and Flag-Ki-KSR1. ** Specific kinase activities of KSR1 proteins were calculated by dividing KSR1 expression by activity and normalizing to the EGF-stimulated low-salt wash value. These results represent 1 of 3 similar experiments. 
